Company intelligence / Profile preview
Green Fields Overseas
Jos, Plateau, Nigeriagreenfieldsoverseas.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Green Fields Overseas Ltd is a Nigeria-based research and biotechnology company founded in 2005 and headquartered in Jos. The company specializes in developing and manufacturing innovative, plant-based pharmaceutical and natural health solutions. Its product portfolio includes Horus Formula4 Eye Care Capsule for ocular health, Tzenova for blood sugar and metabolic support, and PrurX Relief for mosquito bites. Additionally, Green Fields Overseas conducts clinical research, notably its ongoing Vitiligo Programme, which utilizes a synergistic combination of Horus Formula4 and Tzenova to support immune modulation and skin repigmentation.
- Therapeutic areas
- Metabolic DisordersOphthalmologyEndocrinologyDermatology
- Modalities
- Herbal medicineBotanical extract
- Industry
- Pharma
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Green Fields Overseas.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Green Fields Overseas.